Global Finasteride (Oral Route) Supply, Demand and Key Producers, 2024-2030
The global Finasteride (Oral Route) market size is expected to reach $ million by 2030, rising at a market growth of % CAGR during the forecast period (2024-2030).
Finasteride, when taken orally, is a medication used to treat symptoms of benign prostatic hyperplasia (BPH) in men with an enlarged prostate. It is also prescribed to treat male pattern hair loss (androgenetic alopecia) in men. Finasteride works by inhibiting the action of the enzyme 5-alpha reductase, which converts the male hormone testosterone to dihydrotestosterone (DHT). By reducing DHT levels in the body, finasteride helps to shrink the prostate and promote hair regrowth in men with male pattern baldness. It is important to note that finasteride should only be taken as prescribed by a healthcare provider, as it can have side effects and may not be suitable for everyone.
This report studies the global Finasteride (Oral Route) production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Finasteride (Oral Route), and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2023 as the base year. This report explores demand trends and competition, as well as details the characteristics of Finasteride (Oral Route) that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Finasteride (Oral Route) total production and demand, 2019-2030, (K Pcs)
Global Finasteride (Oral Route) total production value, 2019-2030, (USD Million)
Global Finasteride (Oral Route) production by region & country, production, value, CAGR, 2019-2030, (USD Million) & (K Pcs)
Global Finasteride (Oral Route) consumption by region & country, CAGR, 2019-2030 & (K Pcs)
U.S. VS China: Finasteride (Oral Route) domestic production, consumption, key domestic manufacturers and share
Global Finasteride (Oral Route) production by manufacturer, production, price, value and market share 2019-2024, (USD Million) & (K Pcs)
Global Finasteride (Oral Route) production by Type, production, value, CAGR, 2019-2030, (USD Million) & (K Pcs)
Global Finasteride (Oral Route) production by Application production, value, CAGR, 2019-2030, (USD Million) & (K Pcs).
This reports profiles key players in the global Finasteride (Oral Route) market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Merck, Sandoz, Actavis, Cipla, RelonChem, Dr. Reddy, Accord Pharmaceuticals, Hangzhou Kangenbei Pharmaceutical Co., Ltd and Hunan Zhengqing Pharmaceutical Group Co., Ltd, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Finasteride (Oral Route) market.
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Pcs) and average price (US$/Pcs) by manufacturer, by Type, and by Application. Data is given for the years 2019-2030 by year with 2023 as the base year, 2024 as the estimate year, and 2025-2030 as the forecast year.
Global Finasteride (Oral Route) Market, By Region:
1. How big is the global Finasteride (Oral Route) market?
2. What is the demand of the global Finasteride (Oral Route) market?
3. What is the year over year growth of the global Finasteride (Oral Route) market?
4. What is the production and production value of the global Finasteride (Oral Route) market?
5. Who are the key producers in the global Finasteride (Oral Route) market?
Finasteride, when taken orally, is a medication used to treat symptoms of benign prostatic hyperplasia (BPH) in men with an enlarged prostate. It is also prescribed to treat male pattern hair loss (androgenetic alopecia) in men. Finasteride works by inhibiting the action of the enzyme 5-alpha reductase, which converts the male hormone testosterone to dihydrotestosterone (DHT). By reducing DHT levels in the body, finasteride helps to shrink the prostate and promote hair regrowth in men with male pattern baldness. It is important to note that finasteride should only be taken as prescribed by a healthcare provider, as it can have side effects and may not be suitable for everyone.
This report studies the global Finasteride (Oral Route) production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Finasteride (Oral Route), and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2023 as the base year. This report explores demand trends and competition, as well as details the characteristics of Finasteride (Oral Route) that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Finasteride (Oral Route) total production and demand, 2019-2030, (K Pcs)
Global Finasteride (Oral Route) total production value, 2019-2030, (USD Million)
Global Finasteride (Oral Route) production by region & country, production, value, CAGR, 2019-2030, (USD Million) & (K Pcs)
Global Finasteride (Oral Route) consumption by region & country, CAGR, 2019-2030 & (K Pcs)
U.S. VS China: Finasteride (Oral Route) domestic production, consumption, key domestic manufacturers and share
Global Finasteride (Oral Route) production by manufacturer, production, price, value and market share 2019-2024, (USD Million) & (K Pcs)
Global Finasteride (Oral Route) production by Type, production, value, CAGR, 2019-2030, (USD Million) & (K Pcs)
Global Finasteride (Oral Route) production by Application production, value, CAGR, 2019-2030, (USD Million) & (K Pcs).
This reports profiles key players in the global Finasteride (Oral Route) market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Merck, Sandoz, Actavis, Cipla, RelonChem, Dr. Reddy, Accord Pharmaceuticals, Hangzhou Kangenbei Pharmaceutical Co., Ltd and Hunan Zhengqing Pharmaceutical Group Co., Ltd, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Finasteride (Oral Route) market.
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Pcs) and average price (US$/Pcs) by manufacturer, by Type, and by Application. Data is given for the years 2019-2030 by year with 2023 as the base year, 2024 as the estimate year, and 2025-2030 as the forecast year.
Global Finasteride (Oral Route) Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- 1mg
- 5mg
- Urology
- Dermatology
- Merck
- Sandoz
- Actavis
- Cipla
- RelonChem
- Dr. Reddy
- Accord Pharmaceuticals
- Hangzhou Kangenbei Pharmaceutical Co., Ltd
- Hunan Zhengqing Pharmaceutical Group Co., Ltd
- Tianfang Pharmaceutical Co., Ltd
- Hunan Qianjin Xiangjiang Pharmaceutical Co., Ltd
- Zhejiang Xianju Pharmaceutical Co., Ltd
- Shanghai Hyundai Pharmaceutical Co., Ltd
- Hunan Baicao Pharmaceutical Co., Ltd
- Guangdong Yishu Pharmaceutical Co., Ltd
- CR SECCO Pharmaceutical Co., Ltd
- Shanghai Xinya Pharmaceutical Minhang Co., Ltd
- Renhetang Pharmaceutical Company Limited
- Runenberg Pharmaceuticals Ltd
- Nanjing Shenghe Pharmaceutical Co., Ltd
- Nanjing Sea Whale Pharmaceutical Co., Ltd
1. How big is the global Finasteride (Oral Route) market?
2. What is the demand of the global Finasteride (Oral Route) market?
3. What is the year over year growth of the global Finasteride (Oral Route) market?
4. What is the production and production value of the global Finasteride (Oral Route) market?
5. Who are the key producers in the global Finasteride (Oral Route) market?
1 SUPPLY SUMMARY
1.1 Finasteride (Oral Route) Introduction
1.2 World Finasteride (Oral Route) Supply & Forecast
1.2.1 World Finasteride (Oral Route) Production Value (2019 & 2023 & 2030)
1.2.2 World Finasteride (Oral Route) Production (2019-2030)
1.2.3 World Finasteride (Oral Route) Pricing Trends (2019-2030)
1.3 World Finasteride (Oral Route) Production by Region (Based on Production Site)
1.3.1 World Finasteride (Oral Route) Production Value by Region (2019-2030)
1.3.2 World Finasteride (Oral Route) Production by Region (2019-2030)
1.3.3 World Finasteride (Oral Route) Average Price by Region (2019-2030)
1.3.4 North America Finasteride (Oral Route) Production (2019-2030)
1.3.5 Europe Finasteride (Oral Route) Production (2019-2030)
1.3.6 China Finasteride (Oral Route) Production (2019-2030)
1.3.7 Japan Finasteride (Oral Route) Production (2019-2030)
1.4 Market Drivers, Restraints and Trends
1.4.1 Finasteride (Oral Route) Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Finasteride (Oral Route) Major Market Trends
2 DEMAND SUMMARY
2.1 World Finasteride (Oral Route) Demand (2019-2030)
2.2 World Finasteride (Oral Route) Consumption by Region
2.2.1 World Finasteride (Oral Route) Consumption by Region (2019-2024)
2.2.2 World Finasteride (Oral Route) Consumption Forecast by Region (2025-2030)
2.3 United States Finasteride (Oral Route) Consumption (2019-2030)
2.4 China Finasteride (Oral Route) Consumption (2019-2030)
2.5 Europe Finasteride (Oral Route) Consumption (2019-2030)
2.6 Japan Finasteride (Oral Route) Consumption (2019-2030)
2.7 South Korea Finasteride (Oral Route) Consumption (2019-2030)
2.8 ASEAN Finasteride (Oral Route) Consumption (2019-2030)
2.9 India Finasteride (Oral Route) Consumption (2019-2030)
3 WORLD FINASTERIDE (ORAL ROUTE) MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Finasteride (Oral Route) Production Value by Manufacturer (2019-2024)
3.2 World Finasteride (Oral Route) Production by Manufacturer (2019-2024)
3.3 World Finasteride (Oral Route) Average Price by Manufacturer (2019-2024)
3.4 Finasteride (Oral Route) Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Finasteride (Oral Route) Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Finasteride (Oral Route) in 2023
3.5.3 Global Concentration Ratios (CR8) for Finasteride (Oral Route) in 2023
3.6 Finasteride (Oral Route) Market: Overall Company Footprint Analysis
3.6.1 Finasteride (Oral Route) Market: Region Footprint
3.6.2 Finasteride (Oral Route) Market: Company Product Type Footprint
3.6.3 Finasteride (Oral Route) Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Finasteride (Oral Route) Production Value Comparison
4.1.1 United States VS China: Finasteride (Oral Route) Production Value Comparison (2019 & 2023 & 2030)
4.1.2 United States VS China: Finasteride (Oral Route) Production Value Market Share Comparison (2019 & 2023 & 2030)
4.2 United States VS China: Finasteride (Oral Route) Production Comparison
4.2.1 United States VS China: Finasteride (Oral Route) Production Comparison (2019 & 2023 & 2030)
4.2.2 United States VS China: Finasteride (Oral Route) Production Market Share Comparison (2019 & 2023 & 2030)
4.3 United States VS China: Finasteride (Oral Route) Consumption Comparison
4.3.1 United States VS China: Finasteride (Oral Route) Consumption Comparison (2019 & 2023 & 2030)
4.3.2 United States VS China: Finasteride (Oral Route) Consumption Market Share Comparison (2019 & 2023 & 2030)
4.4 United States Based Finasteride (Oral Route) Manufacturers and Market Share, 2019-2024
4.4.1 United States Based Finasteride (Oral Route) Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Finasteride (Oral Route) Production Value (2019-2024)
4.4.3 United States Based Manufacturers Finasteride (Oral Route) Production (2019-2024)
4.5 China Based Finasteride (Oral Route) Manufacturers and Market Share
4.5.1 China Based Finasteride (Oral Route) Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Finasteride (Oral Route) Production Value (2019-2024)
4.5.3 China Based Manufacturers Finasteride (Oral Route) Production (2019-2024)
4.6 Rest of World Based Finasteride (Oral Route) Manufacturers and Market Share, 2019-2024
4.6.1 Rest of World Based Finasteride (Oral Route) Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Finasteride (Oral Route) Production Value (2019-2024)
4.6.3 Rest of World Based Manufacturers Finasteride (Oral Route) Production (2019-2024)
5 MARKET ANALYSIS BY TYPE
5.1 World Finasteride (Oral Route) Market Size Overview by Type: 2019 VS 2023 VS 2030
5.2 Segment Introduction by Type
5.2.1 1mg
5.2.2 5mg
5.3 Market Segment by Type
5.3.1 World Finasteride (Oral Route) Production by Type (2019-2030)
5.3.2 World Finasteride (Oral Route) Production Value by Type (2019-2030)
5.3.3 World Finasteride (Oral Route) Average Price by Type (2019-2030)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Finasteride (Oral Route) Market Size Overview by Application: 2019 VS 2023 VS 2030
6.2 Segment Introduction by Application
6.2.1 Urology
6.2.2 Dermatology
6.3 Market Segment by Application
6.3.1 World Finasteride (Oral Route) Production by Application (2019-2030)
6.3.2 World Finasteride (Oral Route) Production Value by Application (2019-2030)
6.3.3 World Finasteride (Oral Route) Average Price by Application (2019-2030)
7 COMPANY PROFILES
7.1 Merck
7.1.1 Merck Details
7.1.2 Merck Major Business
7.1.3 Merck Finasteride (Oral Route) Product and Services
7.1.4 Merck Finasteride (Oral Route) Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.1.5 Merck Recent Developments/Updates
7.1.6 Merck Competitive Strengths & Weaknesses
7.2 Sandoz
7.2.1 Sandoz Details
7.2.2 Sandoz Major Business
7.2.3 Sandoz Finasteride (Oral Route) Product and Services
7.2.4 Sandoz Finasteride (Oral Route) Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.2.5 Sandoz Recent Developments/Updates
7.2.6 Sandoz Competitive Strengths & Weaknesses
7.3 Actavis
7.3.1 Actavis Details
7.3.2 Actavis Major Business
7.3.3 Actavis Finasteride (Oral Route) Product and Services
7.3.4 Actavis Finasteride (Oral Route) Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.3.5 Actavis Recent Developments/Updates
7.3.6 Actavis Competitive Strengths & Weaknesses
7.4 Cipla
7.4.1 Cipla Details
7.4.2 Cipla Major Business
7.4.3 Cipla Finasteride (Oral Route) Product and Services
7.4.4 Cipla Finasteride (Oral Route) Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.4.5 Cipla Recent Developments/Updates
7.4.6 Cipla Competitive Strengths & Weaknesses
7.5 RelonChem
7.5.1 RelonChem Details
7.5.2 RelonChem Major Business
7.5.3 RelonChem Finasteride (Oral Route) Product and Services
7.5.4 RelonChem Finasteride (Oral Route) Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.5.5 RelonChem Recent Developments/Updates
7.5.6 RelonChem Competitive Strengths & Weaknesses
7.6 Dr. Reddy
7.6.1 Dr. Reddy Details
7.6.2 Dr. Reddy Major Business
7.6.3 Dr. Reddy Finasteride (Oral Route) Product and Services
7.6.4 Dr. Reddy Finasteride (Oral Route) Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.6.5 Dr. Reddy Recent Developments/Updates
7.6.6 Dr. Reddy Competitive Strengths & Weaknesses
7.7 Accord Pharmaceuticals
7.7.1 Accord Pharmaceuticals Details
7.7.2 Accord Pharmaceuticals Major Business
7.7.3 Accord Pharmaceuticals Finasteride (Oral Route) Product and Services
7.7.4 Accord Pharmaceuticals Finasteride (Oral Route) Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.7.5 Accord Pharmaceuticals Recent Developments/Updates
7.7.6 Accord Pharmaceuticals Competitive Strengths & Weaknesses
7.8 Hangzhou Kangenbei Pharmaceutical Co., Ltd
7.8.1 Hangzhou Kangenbei Pharmaceutical Co., Ltd Details
7.8.2 Hangzhou Kangenbei Pharmaceutical Co., Ltd Major Business
7.8.3 Hangzhou Kangenbei Pharmaceutical Co., Ltd Finasteride (Oral Route) Product and Services
7.8.4 Hangzhou Kangenbei Pharmaceutical Co., Ltd Finasteride (Oral Route) Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.8.5 Hangzhou Kangenbei Pharmaceutical Co., Ltd Recent Developments/Updates
7.8.6 Hangzhou Kangenbei Pharmaceutical Co., Ltd Competitive Strengths & Weaknesses
7.9 Hunan Zhengqing Pharmaceutical Group Co., Ltd
7.9.1 Hunan Zhengqing Pharmaceutical Group Co., Ltd Details
7.9.2 Hunan Zhengqing Pharmaceutical Group Co., Ltd Major Business
7.9.3 Hunan Zhengqing Pharmaceutical Group Co., Ltd Finasteride (Oral Route) Product and Services
7.9.4 Hunan Zhengqing Pharmaceutical Group Co., Ltd Finasteride (Oral Route) Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.9.5 Hunan Zhengqing Pharmaceutical Group Co., Ltd Recent Developments/Updates
7.9.6 Hunan Zhengqing Pharmaceutical Group Co., Ltd Competitive Strengths & Weaknesses
7.10 Tianfang Pharmaceutical Co., Ltd
7.10.1 Tianfang Pharmaceutical Co., Ltd Details
7.10.2 Tianfang Pharmaceutical Co., Ltd Major Business
7.10.3 Tianfang Pharmaceutical Co., Ltd Finasteride (Oral Route) Product and Services
7.10.4 Tianfang Pharmaceutical Co., Ltd Finasteride (Oral Route) Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.10.5 Tianfang Pharmaceutical Co., Ltd Recent Developments/Updates
7.10.6 Tianfang Pharmaceutical Co., Ltd Competitive Strengths & Weaknesses
7.11 Hunan Qianjin Xiangjiang Pharmaceutical Co., Ltd
7.11.1 Hunan Qianjin Xiangjiang Pharmaceutical Co., Ltd Details
7.11.2 Hunan Qianjin Xiangjiang Pharmaceutical Co., Ltd Major Business
7.11.3 Hunan Qianjin Xiangjiang Pharmaceutical Co., Ltd Finasteride (Oral Route) Product and Services
7.11.4 Hunan Qianjin Xiangjiang Pharmaceutical Co., Ltd Finasteride (Oral Route) Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.11.5 Hunan Qianjin Xiangjiang Pharmaceutical Co., Ltd Recent Developments/Updates
7.11.6 Hunan Qianjin Xiangjiang Pharmaceutical Co., Ltd Competitive Strengths & Weaknesses
7.12 Zhejiang Xianju Pharmaceutical Co., Ltd
7.12.1 Zhejiang Xianju Pharmaceutical Co., Ltd Details
7.12.2 Zhejiang Xianju Pharmaceutical Co., Ltd Major Business
7.12.3 Zhejiang Xianju Pharmaceutical Co., Ltd Finasteride (Oral Route) Product and Services
7.12.4 Zhejiang Xianju Pharmaceutical Co., Ltd Finasteride (Oral Route) Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.12.5 Zhejiang Xianju Pharmaceutical Co., Ltd Recent Developments/Updates
7.12.6 Zhejiang Xianju Pharmaceutical Co., Ltd Competitive Strengths & Weaknesses
7.13 Shanghai Hyundai Pharmaceutical Co., Ltd
7.13.1 Shanghai Hyundai Pharmaceutical Co., Ltd Details
7.13.2 Shanghai Hyundai Pharmaceutical Co., Ltd Major Business
7.13.3 Shanghai Hyundai Pharmaceutical Co., Ltd Finasteride (Oral Route) Product and Services
7.13.4 Shanghai Hyundai Pharmaceutical Co., Ltd Finasteride (Oral Route) Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.13.5 Shanghai Hyundai Pharmaceutical Co., Ltd Recent Developments/Updates
7.13.6 Shanghai Hyundai Pharmaceutical Co., Ltd Competitive Strengths & Weaknesses
7.14 Hunan Baicao Pharmaceutical Co., Ltd
7.14.1 Hunan Baicao Pharmaceutical Co., Ltd Details
7.14.2 Hunan Baicao Pharmaceutical Co., Ltd Major Business
7.14.3 Hunan Baicao Pharmaceutical Co., Ltd Finasteride (Oral Route) Product and Services
7.14.4 Hunan Baicao Pharmaceutical Co., Ltd Finasteride (Oral Route) Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.14.5 Hunan Baicao Pharmaceutical Co., Ltd Recent Developments/Updates
7.14.6 Hunan Baicao Pharmaceutical Co., Ltd Competitive Strengths & Weaknesses
7.15 Guangdong Yishu Pharmaceutical Co., Ltd
7.15.1 Guangdong Yishu Pharmaceutical Co., Ltd Details
7.15.2 Guangdong Yishu Pharmaceutical Co., Ltd Major Business
7.15.3 Guangdong Yishu Pharmaceutical Co., Ltd Finasteride (Oral Route) Product and Services
7.15.4 Guangdong Yishu Pharmaceutical Co., Ltd Finasteride (Oral Route) Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.15.5 Guangdong Yishu Pharmaceutical Co., Ltd Recent Developments/Updates
7.15.6 Guangdong Yishu Pharmaceutical Co., Ltd Competitive Strengths & Weaknesses
7.16 CR SECCO Pharmaceutical Co., Ltd
7.16.1 CR SECCO Pharmaceutical Co., Ltd Details
7.16.2 CR SECCO Pharmaceutical Co., Ltd Major Business
7.16.3 CR SECCO Pharmaceutical Co., Ltd Finasteride (Oral Route) Product and Services
7.16.4 CR SECCO Pharmaceutical Co., Ltd Finasteride (Oral Route) Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.16.5 CR SECCO Pharmaceutical Co., Ltd Recent Developments/Updates
7.16.6 CR SECCO Pharmaceutical Co., Ltd Competitive Strengths & Weaknesses
7.17 Shanghai Xinya Pharmaceutical Minhang Co., Ltd
7.17.1 Shanghai Xinya Pharmaceutical Minhang Co., Ltd Details
7.17.2 Shanghai Xinya Pharmaceutical Minhang Co., Ltd Major Business
7.17.3 Shanghai Xinya Pharmaceutical Minhang Co., Ltd Finasteride (Oral Route) Product and Services
7.17.4 Shanghai Xinya Pharmaceutical Minhang Co., Ltd Finasteride (Oral Route) Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.17.5 Shanghai Xinya Pharmaceutical Minhang Co., Ltd Recent Developments/Updates
7.17.6 Shanghai Xinya Pharmaceutical Minhang Co., Ltd Competitive Strengths & Weaknesses
7.18 Renhetang Pharmaceutical Company Limited
7.18.1 Renhetang Pharmaceutical Company Limited Details
7.18.2 Renhetang Pharmaceutical Company Limited Major Business
7.18.3 Renhetang Pharmaceutical Company Limited Finasteride (Oral Route) Product and Services
7.18.4 Renhetang Pharmaceutical Company Limited Finasteride (Oral Route) Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.18.5 Renhetang Pharmaceutical Company Limited Recent Developments/Updates
7.18.6 Renhetang Pharmaceutical Company Limited Competitive Strengths & Weaknesses
7.19 Runenberg Pharmaceuticals Ltd
7.19.1 Runenberg Pharmaceuticals Ltd Details
7.19.2 Runenberg Pharmaceuticals Ltd Major Business
7.19.3 Runenberg Pharmaceuticals Ltd Finasteride (Oral Route) Product and Services
7.19.4 Runenberg Pharmaceuticals Ltd Finasteride (Oral Route) Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.19.5 Runenberg Pharmaceuticals Ltd Recent Developments/Updates
7.19.6 Runenberg Pharmaceuticals Ltd Competitive Strengths & Weaknesses
7.20 Nanjing Shenghe Pharmaceutical Co., Ltd
7.20.1 Nanjing Shenghe Pharmaceutical Co., Ltd Details
7.20.2 Nanjing Shenghe Pharmaceutical Co., Ltd Major Business
7.20.3 Nanjing Shenghe Pharmaceutical Co., Ltd Finasteride (Oral Route) Product and Services
7.20.4 Nanjing Shenghe Pharmaceutical Co., Ltd Finasteride (Oral Route) Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.20.5 Nanjing Shenghe Pharmaceutical Co., Ltd Recent Developments/Updates
7.20.6 Nanjing Shenghe Pharmaceutical Co., Ltd Competitive Strengths & Weaknesses
7.21 Nanjing Sea Whale Pharmaceutical Co., Ltd
7.21.1 Nanjing Sea Whale Pharmaceutical Co., Ltd Details
7.21.2 Nanjing Sea Whale Pharmaceutical Co., Ltd Major Business
7.21.3 Nanjing Sea Whale Pharmaceutical Co., Ltd Finasteride (Oral Route) Product and Services
7.21.4 Nanjing Sea Whale Pharmaceutical Co., Ltd Finasteride (Oral Route) Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.21.5 Nanjing Sea Whale Pharmaceutical Co., Ltd Recent Developments/Updates
7.21.6 Nanjing Sea Whale Pharmaceutical Co., Ltd Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Finasteride (Oral Route) Industry Chain
8.2 Finasteride (Oral Route) Upstream Analysis
8.2.1 Finasteride (Oral Route) Core Raw Materials
8.2.2 Main Manufacturers of Finasteride (Oral Route) Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Finasteride (Oral Route) Production Mode
8.6 Finasteride (Oral Route) Procurement Model
8.7 Finasteride (Oral Route) Industry Sales Model and Sales Channels
8.7.1 Finasteride (Oral Route) Sales Model
8.7.2 Finasteride (Oral Route) Typical Customers
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
1.1 Finasteride (Oral Route) Introduction
1.2 World Finasteride (Oral Route) Supply & Forecast
1.2.1 World Finasteride (Oral Route) Production Value (2019 & 2023 & 2030)
1.2.2 World Finasteride (Oral Route) Production (2019-2030)
1.2.3 World Finasteride (Oral Route) Pricing Trends (2019-2030)
1.3 World Finasteride (Oral Route) Production by Region (Based on Production Site)
1.3.1 World Finasteride (Oral Route) Production Value by Region (2019-2030)
1.3.2 World Finasteride (Oral Route) Production by Region (2019-2030)
1.3.3 World Finasteride (Oral Route) Average Price by Region (2019-2030)
1.3.4 North America Finasteride (Oral Route) Production (2019-2030)
1.3.5 Europe Finasteride (Oral Route) Production (2019-2030)
1.3.6 China Finasteride (Oral Route) Production (2019-2030)
1.3.7 Japan Finasteride (Oral Route) Production (2019-2030)
1.4 Market Drivers, Restraints and Trends
1.4.1 Finasteride (Oral Route) Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Finasteride (Oral Route) Major Market Trends
2 DEMAND SUMMARY
2.1 World Finasteride (Oral Route) Demand (2019-2030)
2.2 World Finasteride (Oral Route) Consumption by Region
2.2.1 World Finasteride (Oral Route) Consumption by Region (2019-2024)
2.2.2 World Finasteride (Oral Route) Consumption Forecast by Region (2025-2030)
2.3 United States Finasteride (Oral Route) Consumption (2019-2030)
2.4 China Finasteride (Oral Route) Consumption (2019-2030)
2.5 Europe Finasteride (Oral Route) Consumption (2019-2030)
2.6 Japan Finasteride (Oral Route) Consumption (2019-2030)
2.7 South Korea Finasteride (Oral Route) Consumption (2019-2030)
2.8 ASEAN Finasteride (Oral Route) Consumption (2019-2030)
2.9 India Finasteride (Oral Route) Consumption (2019-2030)
3 WORLD FINASTERIDE (ORAL ROUTE) MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Finasteride (Oral Route) Production Value by Manufacturer (2019-2024)
3.2 World Finasteride (Oral Route) Production by Manufacturer (2019-2024)
3.3 World Finasteride (Oral Route) Average Price by Manufacturer (2019-2024)
3.4 Finasteride (Oral Route) Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Finasteride (Oral Route) Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Finasteride (Oral Route) in 2023
3.5.3 Global Concentration Ratios (CR8) for Finasteride (Oral Route) in 2023
3.6 Finasteride (Oral Route) Market: Overall Company Footprint Analysis
3.6.1 Finasteride (Oral Route) Market: Region Footprint
3.6.2 Finasteride (Oral Route) Market: Company Product Type Footprint
3.6.3 Finasteride (Oral Route) Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Finasteride (Oral Route) Production Value Comparison
4.1.1 United States VS China: Finasteride (Oral Route) Production Value Comparison (2019 & 2023 & 2030)
4.1.2 United States VS China: Finasteride (Oral Route) Production Value Market Share Comparison (2019 & 2023 & 2030)
4.2 United States VS China: Finasteride (Oral Route) Production Comparison
4.2.1 United States VS China: Finasteride (Oral Route) Production Comparison (2019 & 2023 & 2030)
4.2.2 United States VS China: Finasteride (Oral Route) Production Market Share Comparison (2019 & 2023 & 2030)
4.3 United States VS China: Finasteride (Oral Route) Consumption Comparison
4.3.1 United States VS China: Finasteride (Oral Route) Consumption Comparison (2019 & 2023 & 2030)
4.3.2 United States VS China: Finasteride (Oral Route) Consumption Market Share Comparison (2019 & 2023 & 2030)
4.4 United States Based Finasteride (Oral Route) Manufacturers and Market Share, 2019-2024
4.4.1 United States Based Finasteride (Oral Route) Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Finasteride (Oral Route) Production Value (2019-2024)
4.4.3 United States Based Manufacturers Finasteride (Oral Route) Production (2019-2024)
4.5 China Based Finasteride (Oral Route) Manufacturers and Market Share
4.5.1 China Based Finasteride (Oral Route) Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Finasteride (Oral Route) Production Value (2019-2024)
4.5.3 China Based Manufacturers Finasteride (Oral Route) Production (2019-2024)
4.6 Rest of World Based Finasteride (Oral Route) Manufacturers and Market Share, 2019-2024
4.6.1 Rest of World Based Finasteride (Oral Route) Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Finasteride (Oral Route) Production Value (2019-2024)
4.6.3 Rest of World Based Manufacturers Finasteride (Oral Route) Production (2019-2024)
5 MARKET ANALYSIS BY TYPE
5.1 World Finasteride (Oral Route) Market Size Overview by Type: 2019 VS 2023 VS 2030
5.2 Segment Introduction by Type
5.2.1 1mg
5.2.2 5mg
5.3 Market Segment by Type
5.3.1 World Finasteride (Oral Route) Production by Type (2019-2030)
5.3.2 World Finasteride (Oral Route) Production Value by Type (2019-2030)
5.3.3 World Finasteride (Oral Route) Average Price by Type (2019-2030)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Finasteride (Oral Route) Market Size Overview by Application: 2019 VS 2023 VS 2030
6.2 Segment Introduction by Application
6.2.1 Urology
6.2.2 Dermatology
6.3 Market Segment by Application
6.3.1 World Finasteride (Oral Route) Production by Application (2019-2030)
6.3.2 World Finasteride (Oral Route) Production Value by Application (2019-2030)
6.3.3 World Finasteride (Oral Route) Average Price by Application (2019-2030)
7 COMPANY PROFILES
7.1 Merck
7.1.1 Merck Details
7.1.2 Merck Major Business
7.1.3 Merck Finasteride (Oral Route) Product and Services
7.1.4 Merck Finasteride (Oral Route) Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.1.5 Merck Recent Developments/Updates
7.1.6 Merck Competitive Strengths & Weaknesses
7.2 Sandoz
7.2.1 Sandoz Details
7.2.2 Sandoz Major Business
7.2.3 Sandoz Finasteride (Oral Route) Product and Services
7.2.4 Sandoz Finasteride (Oral Route) Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.2.5 Sandoz Recent Developments/Updates
7.2.6 Sandoz Competitive Strengths & Weaknesses
7.3 Actavis
7.3.1 Actavis Details
7.3.2 Actavis Major Business
7.3.3 Actavis Finasteride (Oral Route) Product and Services
7.3.4 Actavis Finasteride (Oral Route) Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.3.5 Actavis Recent Developments/Updates
7.3.6 Actavis Competitive Strengths & Weaknesses
7.4 Cipla
7.4.1 Cipla Details
7.4.2 Cipla Major Business
7.4.3 Cipla Finasteride (Oral Route) Product and Services
7.4.4 Cipla Finasteride (Oral Route) Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.4.5 Cipla Recent Developments/Updates
7.4.6 Cipla Competitive Strengths & Weaknesses
7.5 RelonChem
7.5.1 RelonChem Details
7.5.2 RelonChem Major Business
7.5.3 RelonChem Finasteride (Oral Route) Product and Services
7.5.4 RelonChem Finasteride (Oral Route) Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.5.5 RelonChem Recent Developments/Updates
7.5.6 RelonChem Competitive Strengths & Weaknesses
7.6 Dr. Reddy
7.6.1 Dr. Reddy Details
7.6.2 Dr. Reddy Major Business
7.6.3 Dr. Reddy Finasteride (Oral Route) Product and Services
7.6.4 Dr. Reddy Finasteride (Oral Route) Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.6.5 Dr. Reddy Recent Developments/Updates
7.6.6 Dr. Reddy Competitive Strengths & Weaknesses
7.7 Accord Pharmaceuticals
7.7.1 Accord Pharmaceuticals Details
7.7.2 Accord Pharmaceuticals Major Business
7.7.3 Accord Pharmaceuticals Finasteride (Oral Route) Product and Services
7.7.4 Accord Pharmaceuticals Finasteride (Oral Route) Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.7.5 Accord Pharmaceuticals Recent Developments/Updates
7.7.6 Accord Pharmaceuticals Competitive Strengths & Weaknesses
7.8 Hangzhou Kangenbei Pharmaceutical Co., Ltd
7.8.1 Hangzhou Kangenbei Pharmaceutical Co., Ltd Details
7.8.2 Hangzhou Kangenbei Pharmaceutical Co., Ltd Major Business
7.8.3 Hangzhou Kangenbei Pharmaceutical Co., Ltd Finasteride (Oral Route) Product and Services
7.8.4 Hangzhou Kangenbei Pharmaceutical Co., Ltd Finasteride (Oral Route) Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.8.5 Hangzhou Kangenbei Pharmaceutical Co., Ltd Recent Developments/Updates
7.8.6 Hangzhou Kangenbei Pharmaceutical Co., Ltd Competitive Strengths & Weaknesses
7.9 Hunan Zhengqing Pharmaceutical Group Co., Ltd
7.9.1 Hunan Zhengqing Pharmaceutical Group Co., Ltd Details
7.9.2 Hunan Zhengqing Pharmaceutical Group Co., Ltd Major Business
7.9.3 Hunan Zhengqing Pharmaceutical Group Co., Ltd Finasteride (Oral Route) Product and Services
7.9.4 Hunan Zhengqing Pharmaceutical Group Co., Ltd Finasteride (Oral Route) Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.9.5 Hunan Zhengqing Pharmaceutical Group Co., Ltd Recent Developments/Updates
7.9.6 Hunan Zhengqing Pharmaceutical Group Co., Ltd Competitive Strengths & Weaknesses
7.10 Tianfang Pharmaceutical Co., Ltd
7.10.1 Tianfang Pharmaceutical Co., Ltd Details
7.10.2 Tianfang Pharmaceutical Co., Ltd Major Business
7.10.3 Tianfang Pharmaceutical Co., Ltd Finasteride (Oral Route) Product and Services
7.10.4 Tianfang Pharmaceutical Co., Ltd Finasteride (Oral Route) Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.10.5 Tianfang Pharmaceutical Co., Ltd Recent Developments/Updates
7.10.6 Tianfang Pharmaceutical Co., Ltd Competitive Strengths & Weaknesses
7.11 Hunan Qianjin Xiangjiang Pharmaceutical Co., Ltd
7.11.1 Hunan Qianjin Xiangjiang Pharmaceutical Co., Ltd Details
7.11.2 Hunan Qianjin Xiangjiang Pharmaceutical Co., Ltd Major Business
7.11.3 Hunan Qianjin Xiangjiang Pharmaceutical Co., Ltd Finasteride (Oral Route) Product and Services
7.11.4 Hunan Qianjin Xiangjiang Pharmaceutical Co., Ltd Finasteride (Oral Route) Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.11.5 Hunan Qianjin Xiangjiang Pharmaceutical Co., Ltd Recent Developments/Updates
7.11.6 Hunan Qianjin Xiangjiang Pharmaceutical Co., Ltd Competitive Strengths & Weaknesses
7.12 Zhejiang Xianju Pharmaceutical Co., Ltd
7.12.1 Zhejiang Xianju Pharmaceutical Co., Ltd Details
7.12.2 Zhejiang Xianju Pharmaceutical Co., Ltd Major Business
7.12.3 Zhejiang Xianju Pharmaceutical Co., Ltd Finasteride (Oral Route) Product and Services
7.12.4 Zhejiang Xianju Pharmaceutical Co., Ltd Finasteride (Oral Route) Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.12.5 Zhejiang Xianju Pharmaceutical Co., Ltd Recent Developments/Updates
7.12.6 Zhejiang Xianju Pharmaceutical Co., Ltd Competitive Strengths & Weaknesses
7.13 Shanghai Hyundai Pharmaceutical Co., Ltd
7.13.1 Shanghai Hyundai Pharmaceutical Co., Ltd Details
7.13.2 Shanghai Hyundai Pharmaceutical Co., Ltd Major Business
7.13.3 Shanghai Hyundai Pharmaceutical Co., Ltd Finasteride (Oral Route) Product and Services
7.13.4 Shanghai Hyundai Pharmaceutical Co., Ltd Finasteride (Oral Route) Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.13.5 Shanghai Hyundai Pharmaceutical Co., Ltd Recent Developments/Updates
7.13.6 Shanghai Hyundai Pharmaceutical Co., Ltd Competitive Strengths & Weaknesses
7.14 Hunan Baicao Pharmaceutical Co., Ltd
7.14.1 Hunan Baicao Pharmaceutical Co., Ltd Details
7.14.2 Hunan Baicao Pharmaceutical Co., Ltd Major Business
7.14.3 Hunan Baicao Pharmaceutical Co., Ltd Finasteride (Oral Route) Product and Services
7.14.4 Hunan Baicao Pharmaceutical Co., Ltd Finasteride (Oral Route) Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.14.5 Hunan Baicao Pharmaceutical Co., Ltd Recent Developments/Updates
7.14.6 Hunan Baicao Pharmaceutical Co., Ltd Competitive Strengths & Weaknesses
7.15 Guangdong Yishu Pharmaceutical Co., Ltd
7.15.1 Guangdong Yishu Pharmaceutical Co., Ltd Details
7.15.2 Guangdong Yishu Pharmaceutical Co., Ltd Major Business
7.15.3 Guangdong Yishu Pharmaceutical Co., Ltd Finasteride (Oral Route) Product and Services
7.15.4 Guangdong Yishu Pharmaceutical Co., Ltd Finasteride (Oral Route) Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.15.5 Guangdong Yishu Pharmaceutical Co., Ltd Recent Developments/Updates
7.15.6 Guangdong Yishu Pharmaceutical Co., Ltd Competitive Strengths & Weaknesses
7.16 CR SECCO Pharmaceutical Co., Ltd
7.16.1 CR SECCO Pharmaceutical Co., Ltd Details
7.16.2 CR SECCO Pharmaceutical Co., Ltd Major Business
7.16.3 CR SECCO Pharmaceutical Co., Ltd Finasteride (Oral Route) Product and Services
7.16.4 CR SECCO Pharmaceutical Co., Ltd Finasteride (Oral Route) Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.16.5 CR SECCO Pharmaceutical Co., Ltd Recent Developments/Updates
7.16.6 CR SECCO Pharmaceutical Co., Ltd Competitive Strengths & Weaknesses
7.17 Shanghai Xinya Pharmaceutical Minhang Co., Ltd
7.17.1 Shanghai Xinya Pharmaceutical Minhang Co., Ltd Details
7.17.2 Shanghai Xinya Pharmaceutical Minhang Co., Ltd Major Business
7.17.3 Shanghai Xinya Pharmaceutical Minhang Co., Ltd Finasteride (Oral Route) Product and Services
7.17.4 Shanghai Xinya Pharmaceutical Minhang Co., Ltd Finasteride (Oral Route) Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.17.5 Shanghai Xinya Pharmaceutical Minhang Co., Ltd Recent Developments/Updates
7.17.6 Shanghai Xinya Pharmaceutical Minhang Co., Ltd Competitive Strengths & Weaknesses
7.18 Renhetang Pharmaceutical Company Limited
7.18.1 Renhetang Pharmaceutical Company Limited Details
7.18.2 Renhetang Pharmaceutical Company Limited Major Business
7.18.3 Renhetang Pharmaceutical Company Limited Finasteride (Oral Route) Product and Services
7.18.4 Renhetang Pharmaceutical Company Limited Finasteride (Oral Route) Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.18.5 Renhetang Pharmaceutical Company Limited Recent Developments/Updates
7.18.6 Renhetang Pharmaceutical Company Limited Competitive Strengths & Weaknesses
7.19 Runenberg Pharmaceuticals Ltd
7.19.1 Runenberg Pharmaceuticals Ltd Details
7.19.2 Runenberg Pharmaceuticals Ltd Major Business
7.19.3 Runenberg Pharmaceuticals Ltd Finasteride (Oral Route) Product and Services
7.19.4 Runenberg Pharmaceuticals Ltd Finasteride (Oral Route) Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.19.5 Runenberg Pharmaceuticals Ltd Recent Developments/Updates
7.19.6 Runenberg Pharmaceuticals Ltd Competitive Strengths & Weaknesses
7.20 Nanjing Shenghe Pharmaceutical Co., Ltd
7.20.1 Nanjing Shenghe Pharmaceutical Co., Ltd Details
7.20.2 Nanjing Shenghe Pharmaceutical Co., Ltd Major Business
7.20.3 Nanjing Shenghe Pharmaceutical Co., Ltd Finasteride (Oral Route) Product and Services
7.20.4 Nanjing Shenghe Pharmaceutical Co., Ltd Finasteride (Oral Route) Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.20.5 Nanjing Shenghe Pharmaceutical Co., Ltd Recent Developments/Updates
7.20.6 Nanjing Shenghe Pharmaceutical Co., Ltd Competitive Strengths & Weaknesses
7.21 Nanjing Sea Whale Pharmaceutical Co., Ltd
7.21.1 Nanjing Sea Whale Pharmaceutical Co., Ltd Details
7.21.2 Nanjing Sea Whale Pharmaceutical Co., Ltd Major Business
7.21.3 Nanjing Sea Whale Pharmaceutical Co., Ltd Finasteride (Oral Route) Product and Services
7.21.4 Nanjing Sea Whale Pharmaceutical Co., Ltd Finasteride (Oral Route) Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.21.5 Nanjing Sea Whale Pharmaceutical Co., Ltd Recent Developments/Updates
7.21.6 Nanjing Sea Whale Pharmaceutical Co., Ltd Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Finasteride (Oral Route) Industry Chain
8.2 Finasteride (Oral Route) Upstream Analysis
8.2.1 Finasteride (Oral Route) Core Raw Materials
8.2.2 Main Manufacturers of Finasteride (Oral Route) Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Finasteride (Oral Route) Production Mode
8.6 Finasteride (Oral Route) Procurement Model
8.7 Finasteride (Oral Route) Industry Sales Model and Sales Channels
8.7.1 Finasteride (Oral Route) Sales Model
8.7.2 Finasteride (Oral Route) Typical Customers
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
LIST OF TABLES
Table 1. World Finasteride (Oral Route) Production Value by Region (2019, 2023 and 2030) & (USD Million)
Table 2. World Finasteride (Oral Route) Production Value by Region (2019-2024) & (USD Million)
Table 3. World Finasteride (Oral Route) Production Value by Region (2025-2030) & (USD Million)
Table 4. World Finasteride (Oral Route) Production Value Market Share by Region (2019-2024)
Table 5. World Finasteride (Oral Route) Production Value Market Share by Region (2025-2030)
Table 6. World Finasteride (Oral Route) Production by Region (2019-2024) & (K Pcs)
Table 7. World Finasteride (Oral Route) Production by Region (2025-2030) & (K Pcs)
Table 8. World Finasteride (Oral Route) Production Market Share by Region (2019-2024)
Table 9. World Finasteride (Oral Route) Production Market Share by Region (2025-2030)
Table 10. World Finasteride (Oral Route) Average Price by Region (2019-2024) & (US$/Pcs)
Table 11. World Finasteride (Oral Route) Average Price by Region (2025-2030) & (US$/Pcs)
Table 12. Finasteride (Oral Route) Major Market Trends
Table 13. World Finasteride (Oral Route) Consumption Growth Rate Forecast by Region (2019 & 2023 & 2030) & (K Pcs)
Table 14. World Finasteride (Oral Route) Consumption by Region (2019-2024) & (K Pcs)
Table 15. World Finasteride (Oral Route) Consumption Forecast by Region (2025-2030) & (K Pcs)
Table 16. World Finasteride (Oral Route) Production Value by Manufacturer (2019-2024) & (USD Million)
Table 17. Production Value Market Share of Key Finasteride (Oral Route) Producers in 2023
Table 18. World Finasteride (Oral Route) Production by Manufacturer (2019-2024) & (K Pcs)
Table 19. Production Market Share of Key Finasteride (Oral Route) Producers in 2023
Table 20. World Finasteride (Oral Route) Average Price by Manufacturer (2019-2024) & (US$/Pcs)
Table 21. Global Finasteride (Oral Route) Company Evaluation Quadrant
Table 22. World Finasteride (Oral Route) Industry Rank of Major Manufacturers, Based on Production Value in 2023
Table 23. Head Office and Finasteride (Oral Route) Production Site of Key Manufacturer
Table 24. Finasteride (Oral Route) Market: Company Product Type Footprint
Table 25. Finasteride (Oral Route) Market: Company Product Application Footprint
Table 26. Finasteride (Oral Route) Competitive Factors
Table 27. Finasteride (Oral Route) New Entrant and Capacity Expansion Plans
Table 28. Finasteride (Oral Route) Mergers & Acquisitions Activity
Table 29. United States VS China Finasteride (Oral Route) Production Value Comparison, (2019 & 2023 & 2030) & (USD Million)
Table 30. United States VS China Finasteride (Oral Route) Production Comparison, (2019 & 2023 & 2030) & (K Pcs)
Table 31. United States VS China Finasteride (Oral Route) Consumption Comparison, (2019 & 2023 & 2030) & (K Pcs)
Table 32. United States Based Finasteride (Oral Route) Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Finasteride (Oral Route) Production Value, (2019-2024) & (USD Million)
Table 34. United States Based Manufacturers Finasteride (Oral Route) Production Value Market Share (2019-2024)
Table 35. United States Based Manufacturers Finasteride (Oral Route) Production (2019-2024) & (K Pcs)
Table 36. United States Based Manufacturers Finasteride (Oral Route) Production Market Share (2019-2024)
Table 37. China Based Finasteride (Oral Route) Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Finasteride (Oral Route) Production Value, (2019-2024) & (USD Million)
Table 39. China Based Manufacturers Finasteride (Oral Route) Production Value Market Share (2019-2024)
Table 40. China Based Manufacturers Finasteride (Oral Route) Production (2019-2024) & (K Pcs)
Table 41. China Based Manufacturers Finasteride (Oral Route) Production Market Share (2019-2024)
Table 42. Rest of World Based Finasteride (Oral Route) Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers Finasteride (Oral Route) Production Value, (2019-2024) & (USD Million)
Table 44. Rest of World Based Manufacturers Finasteride (Oral Route) Production Value Market Share (2019-2024)
Table 45. Rest of World Based Manufacturers Finasteride (Oral Route) Production (2019-2024) & (K Pcs)
Table 46. Rest of World Based Manufacturers Finasteride (Oral Route) Production Market Share (2019-2024)
Table 47. World Finasteride (Oral Route) Production Value by Type, (USD Million), 2019 & 2023 & 2030
Table 48. World Finasteride (Oral Route) Production by Type (2019-2024) & (K Pcs)
Table 49. World Finasteride (Oral Route) Production by Type (2025-2030) & (K Pcs)
Table 50. World Finasteride (Oral Route) Production Value by Type (2019-2024) & (USD Million)
Table 51. World Finasteride (Oral Route) Production Value by Type (2025-2030) & (USD Million)
Table 52. World Finasteride (Oral Route) Average Price by Type (2019-2024) & (US$/Pcs)
Table 53. World Finasteride (Oral Route) Average Price by Type (2025-2030) & (US$/Pcs)
Table 54. World Finasteride (Oral Route) Production Value by Application, (USD Million), 2019 & 2023 & 2030
Table 55. World Finasteride (Oral Route) Production by Application (2019-2024) & (K Pcs)
Table 56. World Finasteride (Oral Route) Production by Application (2025-2030) & (K Pcs)
Table 57. World Finasteride (Oral Route) Production Value by Application (2019-2024) & (USD Million)
Table 58. World Finasteride (Oral Route) Production Value by Application (2025-2030) & (USD Million)
Table 59. World Finasteride (Oral Route) Average Price by Application (2019-2024) & (US$/Pcs)
Table 60. World Finasteride (Oral Route) Average Price by Application (2025-2030) & (US$/Pcs)
Table 61. Merck Basic Information, Manufacturing Base and Competitors
Table 62. Merck Major Business
Table 63. Merck Finasteride (Oral Route) Product and Services
Table 64. Merck Finasteride (Oral Route) Production (K Pcs), Price (US$/Pcs), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 65. Merck Recent Developments/Updates
Table 66. Merck Competitive Strengths & Weaknesses
Table 67. Sandoz Basic Information, Manufacturing Base and Competitors
Table 68. Sandoz Major Business
Table 69. Sandoz Finasteride (Oral Route) Product and Services
Table 70. Sandoz Finasteride (Oral Route) Production (K Pcs), Price (US$/Pcs), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 71. Sandoz Recent Developments/Updates
Table 72. Sandoz Competitive Strengths & Weaknesses
Table 73. Actavis Basic Information, Manufacturing Base and Competitors
Table 74. Actavis Major Business
Table 75. Actavis Finasteride (Oral Route) Product and Services
Table 76. Actavis Finasteride (Oral Route) Production (K Pcs), Price (US$/Pcs), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 77. Actavis Recent Developments/Updates
Table 78. Actavis Competitive Strengths & Weaknesses
Table 79. Cipla Basic Information, Manufacturing Base and Competitors
Table 80. Cipla Major Business
Table 81. Cipla Finasteride (Oral Route) Product and Services
Table 82. Cipla Finasteride (Oral Route) Production (K Pcs), Price (US$/Pcs), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 83. Cipla Recent Developments/Updates
Table 84. Cipla Competitive Strengths & Weaknesses
Table 85. RelonChem Basic Information, Manufacturing Base and Competitors
Table 86. RelonChem Major Business
Table 87. RelonChem Finasteride (Oral Route) Product and Services
Table 88. RelonChem Finasteride (Oral Route) Production (K Pcs), Price (US$/Pcs), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 89. RelonChem Recent Developments/Updates
Table 90. RelonChem Competitive Strengths & Weaknesses
Table 91. Dr. Reddy Basic Information, Manufacturing Base and Competitors
Table 92. Dr. Reddy Major Business
Table 93. Dr. Reddy Finasteride (Oral Route) Product and Services
Table 94. Dr. Reddy Finasteride (Oral Route) Production (K Pcs), Price (US$/Pcs), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 95. Dr. Reddy Recent Developments/Updates
Table 96. Dr. Reddy Competitive Strengths & Weaknesses
Table 97. Accord Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 98. Accord Pharmaceuticals Major Business
Table 99. Accord Pharmaceuticals Finasteride (Oral Route) Product and Services
Table 100. Accord Pharmaceuticals Finasteride (Oral Route) Production (K Pcs), Price (US$/Pcs), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 101. Accord Pharmaceuticals Recent Developments/Updates
Table 102. Accord Pharmaceuticals Competitive Strengths & Weaknesses
Table 103. Hangzhou Kangenbei Pharmaceutical Co., Ltd Basic Information, Manufacturing Base and Competitors
Table 104. Hangzhou Kangenbei Pharmaceutical Co., Ltd Major Business
Table 105. Hangzhou Kangenbei Pharmaceutical Co., Ltd Finasteride (Oral Route) Product and Services
Table 106. Hangzhou Kangenbei Pharmaceutical Co., Ltd Finasteride (Oral Route) Production (K Pcs), Price (US$/Pcs), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 107. Hangzhou Kangenbei Pharmaceutical Co., Ltd Recent Developments/Updates
Table 108. Hangzhou Kangenbei Pharmaceutical Co., Ltd Competitive Strengths & Weaknesses
Table 109. Hunan Zhengqing Pharmaceutical Group Co., Ltd Basic Information, Manufacturing Base and Competitors
Table 110. Hunan Zhengqing Pharmaceutical Group Co., Ltd Major Business
Table 111. Hunan Zhengqing Pharmaceutical Group Co., Ltd Finasteride (Oral Route) Product and Services
Table 112. Hunan Zhengqing Pharmaceutical Group Co., Ltd Finasteride (Oral Route) Production (K Pcs), Price (US$/Pcs), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 113. Hunan Zhengqing Pharmaceutical Group Co., Ltd Recent Developments/Updates
Table 114. Hunan Zhengqing Pharmaceutical Group Co., Ltd Competitive Strengths & Weaknesses
Table 115. Tianfang Pharmaceutical Co., Ltd Basic Information, Manufacturing Base and Competitors
Table 116. Tianfang Pharmaceutical Co., Ltd Major Business
Table 117. Tianfang Pharmaceutical Co., Ltd Finasteride (Oral Route) Product and Services
Table 118. Tianfang Pharmaceutical Co., Ltd Finasteride (Oral Route) Production (K Pcs), Price (US$/Pcs), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 119. Tianfang Pharmaceutical Co., Ltd Recent Developments/Updates
Table 120. Tianfang Pharmaceutical Co., Ltd Competitive Strengths & Weaknesses
Table 121. Hunan Qianjin Xiangjiang Pharmaceutical Co., Ltd Basic Information, Manufacturing Base and Competitors
Table 122. Hunan Qianjin Xiangjiang Pharmaceutical Co., Ltd Major Business
Table 123. Hunan Qianjin Xiangjiang Pharmaceutical Co., Ltd Finasteride (Oral Route) Product and Services
Table 124. Hunan Qianjin Xiangjiang Pharmaceutical Co., Ltd Finasteride (Oral Route) Production (K Pcs), Price (US$/Pcs), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 125. Hunan Qianjin Xiangjiang Pharmaceutical Co., Ltd Recent Developments/Updates
Table 126. Hunan Qianjin Xiangjiang Pharmaceutical Co., Ltd Competitive Strengths & Weaknesses
Table 127. Zhejiang Xianju Pharmaceutical Co., Ltd Basic Information, Manufacturing Base and Competitors
Table 128. Zhejiang Xianju Pharmaceutical Co., Ltd Major Business
Table 129. Zhejiang Xianju Pharmaceutical Co., Ltd Finasteride (Oral Route) Product and Services
Table 130. Zhejiang Xianju Pharmaceutical Co., Ltd Finasteride (Oral Route) Production (K Pcs), Price (US$/Pcs), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 131. Zhejiang Xianju Pharmaceutical Co., Ltd Recent Developments/Updates
Table 132. Zhejiang Xianju Pharmaceutical Co., Ltd Competitive Strengths & Weaknesses
Table 133. Shanghai Hyundai Pharmaceutical Co., Ltd Basic Information, Manufacturing Base and Competitors
Table 134. Shanghai Hyundai Pharmaceutical Co., Ltd Major Business
Table 135. Shanghai Hyundai Pharmaceutical Co., Ltd Finasteride (Oral Route) Product and Services
Table 136. Shanghai Hyundai Pharmaceutical Co., Ltd Finasteride (Oral Route) Production (K Pcs), Price (US$/Pcs), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 137. Shanghai Hyundai Pharmaceutical Co., Ltd Recent Developments/Updates
Table 138. Shanghai Hyundai Pharmaceutical Co., Ltd Competitive Strengths & Weaknesses
Table 139. Hunan Baicao Pharmaceutical Co., Ltd Basic Information, Manufacturing Base and Competitors
Table 140. Hunan Baicao Pharmaceutical Co., Ltd Major Business
Table 141. Hunan Baicao Pharmaceutical Co., Ltd Finasteride (Oral Route) Product and Services
Table 142. Hunan Baicao Pharmaceutical Co., Ltd Finasteride (Oral Route) Production (K Pcs), Price (US$/Pcs), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 143. Hunan Baicao Pharmaceutical Co., Ltd Recent Developments/Updates
Table 144. Hunan Baicao Pharmaceutical Co., Ltd Competitive Strengths & Weaknesses
Table 145. Guangdong Yishu Pharmaceutical Co., Ltd Basic Information, Manufacturing Base and Competitors
Table 146. Guangdong Yishu Pharmaceutical Co., Ltd Major Business
Table 147. Guangdong Yishu Pharmaceutical Co., Ltd Finasteride (Oral Route) Product and Services
Table 148. Guangdong Yishu Pharmaceutical Co., Ltd Finasteride (Oral Route) Production (K Pcs), Price (US$/Pcs), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 149. Guangdong Yishu Pharmaceutical Co., Ltd Recent Developments/Updates
Table 150. Guangdong Yishu Pharmaceutical Co., Ltd Competitive Strengths & Weaknesses
Table 151. CR SECCO Pharmaceutical Co., Ltd Basic Information, Manufacturing Base and Competitors
Table 152. CR SECCO Pharmaceutical Co., Ltd Major Business
Table 153. CR SECCO Pharmaceutical Co., Ltd Finasteride (Oral Route) Product and Services
Table 154. CR SECCO Pharmaceutical Co., Ltd Finasteride (Oral Route) Production (K Pcs), Price (US$/Pcs), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 155. CR SECCO Pharmaceutical Co., Ltd Recent Developments/Updates
Table 156. CR SECCO Pharmaceutical Co., Ltd Competitive Strengths & Weaknesses
Table 157. Shanghai Xinya Pharmaceutical Minhang Co., Ltd Basic Information, Manufacturing Base and Competitors
Table 158. Shanghai Xinya Pharmaceutical Minhang Co., Ltd Major Business
Table 159. Shanghai Xinya Pharmaceutical Minhang Co., Ltd Finasteride (Oral Route) Product and Services
Table 160. Shanghai Xinya Pharmaceutical Minhang Co., Ltd Finasteride (Oral Route) Production (K Pcs), Price (US$/Pcs), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 161. Shanghai Xinya Pharmaceutical Minhang Co., Ltd Recent Developments/Updates
Table 162. Shanghai Xinya Pharmaceutical Minhang Co., Ltd Competitive Strengths & Weaknesses
Table 163. Renhetang Pharmaceutical Company Limited Basic Information, Manufacturing Base and Competitors
Table 164. Renhetang Pharmaceutical Company Limited Major Business
Table 165. Renhetang Pharmaceutical Company Limited Finasteride (Oral Route) Product and Services
Table 166. Renhetang Pharmaceutical Company Limited Finasteride (Oral Route) Production (K Pcs), Price (US$/Pcs), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 167. Renhetang Pharmaceutical Company Limited Recent Developments/Updates
Table 168. Renhetang Pharmaceutical Company Limited Competitive Strengths & Weaknesses
Table 169. Runenberg Pharmaceuticals Ltd Basic Information, Manufacturing Base and Competitors
Table 170. Runenberg Pharmaceuticals Ltd Major Business
Table 171. Runenberg Pharmaceuticals Ltd Finasteride (Oral Route) Product and Services
Table 172. Runenberg Pharmaceuticals Ltd Finasteride (Oral Route) Production (K Pcs), Price (US$/Pcs), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 173. Runenberg Pharmaceuticals Ltd Recent Developments/Updates
Table 174. Runenberg Pharmaceuticals Ltd Competitive Strengths & Weaknesses
Table 175. Nanjing Shenghe Pharmaceutical Co., Ltd Basic Information, Manufacturing Base and Competitors
Table 176. Nanjing Shenghe Pharmaceutical Co., Ltd Major Business
Table 177. Nanjing Shenghe Pharmaceutical Co., Ltd Finasteride (Oral Route) Product and Services
Table 178. Nanjing Shenghe Pharmaceutical Co., Ltd Finasteride (Oral Route) Production (K Pcs), Price (US$/Pcs), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 179. Nanjing Shenghe Pharmaceutical Co., Ltd Recent Developments/Updates
Table 180. Nanjing Sea Whale Pharmaceutical Co., Ltd Basic Information, Manufacturing Base and Competitors
Table 181. Nanjing Sea Whale Pharmaceutical Co., Ltd Major Business
Table 182. Nanjing Sea Whale Pharmaceutical Co., Ltd Finasteride (Oral Route) Product and Services
Table 183. Nanjing Sea Whale Pharmaceutical Co., Ltd Finasteride (Oral Route) Production (K Pcs), Price (US$/Pcs), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 184. Global Key Players of Finasteride (Oral Route) Upstream (Raw Materials)
Table 185. Finasteride (Oral Route) Typical Customers
Table 186. Finasteride (Oral Route) Typical Distributors
LIST OF FIGURE
Figure 1. Finasteride (Oral Route) Picture
Figure 2. World Finasteride (Oral Route) Production Value: 2019 & 2023 & 2030, (USD Million)
Figure 3. World Finasteride (Oral Route) Production Value and Forecast (2019-2030) & (USD Million)
Figure 4. World Finasteride (Oral Route) Production (2019-2030) & (K Pcs)
Figure 5. World Finasteride (Oral Route) Average Price (2019-2030) & (US$/Pcs)
Figure 6. World Finasteride (Oral Route) Production Value Market Share by Region (2019-2030)
Figure 7. World Finasteride (Oral Route) Production Market Share by Region (2019-2030)
Figure 8. North America Finasteride (Oral Route) Production (2019-2030) & (K Pcs)
Figure 9. Europe Finasteride (Oral Route) Production (2019-2030) & (K Pcs)
Figure 10. China Finasteride (Oral Route) Production (2019-2030) & (K Pcs)
Figure 11. Japan Finasteride (Oral Route) Production (2019-2030) & (K Pcs)
Figure 12. Finasteride (Oral Route) Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Finasteride (Oral Route) Consumption (2019-2030) & (K Pcs)
Figure 15. World Finasteride (Oral Route) Consumption Market Share by Region (2019-2030)
Figure 16. United States Finasteride (Oral Route) Consumption (2019-2030) & (K Pcs)
Figure 17. China Finasteride (Oral Route) Consumption (2019-2030) & (K Pcs)
Figure 18. Europe Finasteride (Oral Route) Consumption (2019-2030) & (K Pcs)
Figure 19. Japan Finasteride (Oral Route) Consumption (2019-2030) & (K Pcs)
Figure 20. South Korea Finasteride (Oral Route) Consumption (2019-2030) & (K Pcs)
Figure 21. ASEAN Finasteride (Oral Route) Consumption (2019-2030) & (K Pcs)
Figure 22. India Finasteride (Oral Route) Consumption (2019-2030) & (K Pcs)
Figure 23. Producer Shipments of Finasteride (Oral Route) by Manufacturer Revenue ($MM) and Market Share (%): 2023
Figure 24. Global Four-firm Concentration Ratios (CR4) for Finasteride (Oral Route) Markets in 2023
Figure 25. Global Four-firm Concentration Ratios (CR8) for Finasteride (Oral Route) Markets in 2023
Figure 26. United States VS China: Finasteride (Oral Route) Production Value Market Share Comparison (2019 & 2023 & 2030)
Figure 27. United States VS China: Finasteride (Oral Route) Production Market Share Comparison (2019 & 2023 & 2030)
Figure 28. United States VS China: Finasteride (Oral Route) Consumption Market Share Comparison (2019 & 2023 & 2030)
Figure 29. United States Based Manufacturers Finasteride (Oral Route) Production Market Share 2023
Figure 30. China Based Manufacturers Finasteride (Oral Route) Production Market Share 2023
Figure 31. Rest of World Based Manufacturers Finasteride (Oral Route) Production Market Share 2023
Figure 32. World Finasteride (Oral Route) Production Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 33. World Finasteride (Oral Route) Production Value Market Share by Type in 2023
Figure 34. 1mg
Figure 35. 5mg
Figure 36. World Finasteride (Oral Route) Production Market Share by Type (2019-2030)
Figure 37. World Finasteride (Oral Route) Production Value Market Share by Type (2019-2030)
Figure 38. World Finasteride (Oral Route) Average Price by Type (2019-2030) & (US$/Pcs)
Figure 39. World Finasteride (Oral Route) Production Value by Application, (USD Million), 2019 & 2023 & 2030
Figure 40. World Finasteride (Oral Route) Production Value Market Share by Application in 2023
Figure 41. Urology
Figure 42. Dermatology
Figure 43. World Finasteride (Oral Route) Production Market Share by Application (2019-2030)
Figure 44. World Finasteride (Oral Route) Production Value Market Share by Application (2019-2030)
Figure 45. World Finasteride (Oral Route) Average Price by Application (2019-2030) & (US$/Pcs)
Figure 46. Finasteride (Oral Route) Industry Chain
Figure 47. Finasteride (Oral Route) Procurement Model
Figure 48. Finasteride (Oral Route) Sales Model
Figure 49. Finasteride (Oral Route) Sales Channels, Direct Sales, and Distribution
Figure 50. Methodology
Figure 51. Research Process and Data Source
Table 1. World Finasteride (Oral Route) Production Value by Region (2019, 2023 and 2030) & (USD Million)
Table 2. World Finasteride (Oral Route) Production Value by Region (2019-2024) & (USD Million)
Table 3. World Finasteride (Oral Route) Production Value by Region (2025-2030) & (USD Million)
Table 4. World Finasteride (Oral Route) Production Value Market Share by Region (2019-2024)
Table 5. World Finasteride (Oral Route) Production Value Market Share by Region (2025-2030)
Table 6. World Finasteride (Oral Route) Production by Region (2019-2024) & (K Pcs)
Table 7. World Finasteride (Oral Route) Production by Region (2025-2030) & (K Pcs)
Table 8. World Finasteride (Oral Route) Production Market Share by Region (2019-2024)
Table 9. World Finasteride (Oral Route) Production Market Share by Region (2025-2030)
Table 10. World Finasteride (Oral Route) Average Price by Region (2019-2024) & (US$/Pcs)
Table 11. World Finasteride (Oral Route) Average Price by Region (2025-2030) & (US$/Pcs)
Table 12. Finasteride (Oral Route) Major Market Trends
Table 13. World Finasteride (Oral Route) Consumption Growth Rate Forecast by Region (2019 & 2023 & 2030) & (K Pcs)
Table 14. World Finasteride (Oral Route) Consumption by Region (2019-2024) & (K Pcs)
Table 15. World Finasteride (Oral Route) Consumption Forecast by Region (2025-2030) & (K Pcs)
Table 16. World Finasteride (Oral Route) Production Value by Manufacturer (2019-2024) & (USD Million)
Table 17. Production Value Market Share of Key Finasteride (Oral Route) Producers in 2023
Table 18. World Finasteride (Oral Route) Production by Manufacturer (2019-2024) & (K Pcs)
Table 19. Production Market Share of Key Finasteride (Oral Route) Producers in 2023
Table 20. World Finasteride (Oral Route) Average Price by Manufacturer (2019-2024) & (US$/Pcs)
Table 21. Global Finasteride (Oral Route) Company Evaluation Quadrant
Table 22. World Finasteride (Oral Route) Industry Rank of Major Manufacturers, Based on Production Value in 2023
Table 23. Head Office and Finasteride (Oral Route) Production Site of Key Manufacturer
Table 24. Finasteride (Oral Route) Market: Company Product Type Footprint
Table 25. Finasteride (Oral Route) Market: Company Product Application Footprint
Table 26. Finasteride (Oral Route) Competitive Factors
Table 27. Finasteride (Oral Route) New Entrant and Capacity Expansion Plans
Table 28. Finasteride (Oral Route) Mergers & Acquisitions Activity
Table 29. United States VS China Finasteride (Oral Route) Production Value Comparison, (2019 & 2023 & 2030) & (USD Million)
Table 30. United States VS China Finasteride (Oral Route) Production Comparison, (2019 & 2023 & 2030) & (K Pcs)
Table 31. United States VS China Finasteride (Oral Route) Consumption Comparison, (2019 & 2023 & 2030) & (K Pcs)
Table 32. United States Based Finasteride (Oral Route) Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Finasteride (Oral Route) Production Value, (2019-2024) & (USD Million)
Table 34. United States Based Manufacturers Finasteride (Oral Route) Production Value Market Share (2019-2024)
Table 35. United States Based Manufacturers Finasteride (Oral Route) Production (2019-2024) & (K Pcs)
Table 36. United States Based Manufacturers Finasteride (Oral Route) Production Market Share (2019-2024)
Table 37. China Based Finasteride (Oral Route) Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Finasteride (Oral Route) Production Value, (2019-2024) & (USD Million)
Table 39. China Based Manufacturers Finasteride (Oral Route) Production Value Market Share (2019-2024)
Table 40. China Based Manufacturers Finasteride (Oral Route) Production (2019-2024) & (K Pcs)
Table 41. China Based Manufacturers Finasteride (Oral Route) Production Market Share (2019-2024)
Table 42. Rest of World Based Finasteride (Oral Route) Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers Finasteride (Oral Route) Production Value, (2019-2024) & (USD Million)
Table 44. Rest of World Based Manufacturers Finasteride (Oral Route) Production Value Market Share (2019-2024)
Table 45. Rest of World Based Manufacturers Finasteride (Oral Route) Production (2019-2024) & (K Pcs)
Table 46. Rest of World Based Manufacturers Finasteride (Oral Route) Production Market Share (2019-2024)
Table 47. World Finasteride (Oral Route) Production Value by Type, (USD Million), 2019 & 2023 & 2030
Table 48. World Finasteride (Oral Route) Production by Type (2019-2024) & (K Pcs)
Table 49. World Finasteride (Oral Route) Production by Type (2025-2030) & (K Pcs)
Table 50. World Finasteride (Oral Route) Production Value by Type (2019-2024) & (USD Million)
Table 51. World Finasteride (Oral Route) Production Value by Type (2025-2030) & (USD Million)
Table 52. World Finasteride (Oral Route) Average Price by Type (2019-2024) & (US$/Pcs)
Table 53. World Finasteride (Oral Route) Average Price by Type (2025-2030) & (US$/Pcs)
Table 54. World Finasteride (Oral Route) Production Value by Application, (USD Million), 2019 & 2023 & 2030
Table 55. World Finasteride (Oral Route) Production by Application (2019-2024) & (K Pcs)
Table 56. World Finasteride (Oral Route) Production by Application (2025-2030) & (K Pcs)
Table 57. World Finasteride (Oral Route) Production Value by Application (2019-2024) & (USD Million)
Table 58. World Finasteride (Oral Route) Production Value by Application (2025-2030) & (USD Million)
Table 59. World Finasteride (Oral Route) Average Price by Application (2019-2024) & (US$/Pcs)
Table 60. World Finasteride (Oral Route) Average Price by Application (2025-2030) & (US$/Pcs)
Table 61. Merck Basic Information, Manufacturing Base and Competitors
Table 62. Merck Major Business
Table 63. Merck Finasteride (Oral Route) Product and Services
Table 64. Merck Finasteride (Oral Route) Production (K Pcs), Price (US$/Pcs), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 65. Merck Recent Developments/Updates
Table 66. Merck Competitive Strengths & Weaknesses
Table 67. Sandoz Basic Information, Manufacturing Base and Competitors
Table 68. Sandoz Major Business
Table 69. Sandoz Finasteride (Oral Route) Product and Services
Table 70. Sandoz Finasteride (Oral Route) Production (K Pcs), Price (US$/Pcs), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 71. Sandoz Recent Developments/Updates
Table 72. Sandoz Competitive Strengths & Weaknesses
Table 73. Actavis Basic Information, Manufacturing Base and Competitors
Table 74. Actavis Major Business
Table 75. Actavis Finasteride (Oral Route) Product and Services
Table 76. Actavis Finasteride (Oral Route) Production (K Pcs), Price (US$/Pcs), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 77. Actavis Recent Developments/Updates
Table 78. Actavis Competitive Strengths & Weaknesses
Table 79. Cipla Basic Information, Manufacturing Base and Competitors
Table 80. Cipla Major Business
Table 81. Cipla Finasteride (Oral Route) Product and Services
Table 82. Cipla Finasteride (Oral Route) Production (K Pcs), Price (US$/Pcs), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 83. Cipla Recent Developments/Updates
Table 84. Cipla Competitive Strengths & Weaknesses
Table 85. RelonChem Basic Information, Manufacturing Base and Competitors
Table 86. RelonChem Major Business
Table 87. RelonChem Finasteride (Oral Route) Product and Services
Table 88. RelonChem Finasteride (Oral Route) Production (K Pcs), Price (US$/Pcs), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 89. RelonChem Recent Developments/Updates
Table 90. RelonChem Competitive Strengths & Weaknesses
Table 91. Dr. Reddy Basic Information, Manufacturing Base and Competitors
Table 92. Dr. Reddy Major Business
Table 93. Dr. Reddy Finasteride (Oral Route) Product and Services
Table 94. Dr. Reddy Finasteride (Oral Route) Production (K Pcs), Price (US$/Pcs), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 95. Dr. Reddy Recent Developments/Updates
Table 96. Dr. Reddy Competitive Strengths & Weaknesses
Table 97. Accord Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 98. Accord Pharmaceuticals Major Business
Table 99. Accord Pharmaceuticals Finasteride (Oral Route) Product and Services
Table 100. Accord Pharmaceuticals Finasteride (Oral Route) Production (K Pcs), Price (US$/Pcs), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 101. Accord Pharmaceuticals Recent Developments/Updates
Table 102. Accord Pharmaceuticals Competitive Strengths & Weaknesses
Table 103. Hangzhou Kangenbei Pharmaceutical Co., Ltd Basic Information, Manufacturing Base and Competitors
Table 104. Hangzhou Kangenbei Pharmaceutical Co., Ltd Major Business
Table 105. Hangzhou Kangenbei Pharmaceutical Co., Ltd Finasteride (Oral Route) Product and Services
Table 106. Hangzhou Kangenbei Pharmaceutical Co., Ltd Finasteride (Oral Route) Production (K Pcs), Price (US$/Pcs), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 107. Hangzhou Kangenbei Pharmaceutical Co., Ltd Recent Developments/Updates
Table 108. Hangzhou Kangenbei Pharmaceutical Co., Ltd Competitive Strengths & Weaknesses
Table 109. Hunan Zhengqing Pharmaceutical Group Co., Ltd Basic Information, Manufacturing Base and Competitors
Table 110. Hunan Zhengqing Pharmaceutical Group Co., Ltd Major Business
Table 111. Hunan Zhengqing Pharmaceutical Group Co., Ltd Finasteride (Oral Route) Product and Services
Table 112. Hunan Zhengqing Pharmaceutical Group Co., Ltd Finasteride (Oral Route) Production (K Pcs), Price (US$/Pcs), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 113. Hunan Zhengqing Pharmaceutical Group Co., Ltd Recent Developments/Updates
Table 114. Hunan Zhengqing Pharmaceutical Group Co., Ltd Competitive Strengths & Weaknesses
Table 115. Tianfang Pharmaceutical Co., Ltd Basic Information, Manufacturing Base and Competitors
Table 116. Tianfang Pharmaceutical Co., Ltd Major Business
Table 117. Tianfang Pharmaceutical Co., Ltd Finasteride (Oral Route) Product and Services
Table 118. Tianfang Pharmaceutical Co., Ltd Finasteride (Oral Route) Production (K Pcs), Price (US$/Pcs), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 119. Tianfang Pharmaceutical Co., Ltd Recent Developments/Updates
Table 120. Tianfang Pharmaceutical Co., Ltd Competitive Strengths & Weaknesses
Table 121. Hunan Qianjin Xiangjiang Pharmaceutical Co., Ltd Basic Information, Manufacturing Base and Competitors
Table 122. Hunan Qianjin Xiangjiang Pharmaceutical Co., Ltd Major Business
Table 123. Hunan Qianjin Xiangjiang Pharmaceutical Co., Ltd Finasteride (Oral Route) Product and Services
Table 124. Hunan Qianjin Xiangjiang Pharmaceutical Co., Ltd Finasteride (Oral Route) Production (K Pcs), Price (US$/Pcs), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 125. Hunan Qianjin Xiangjiang Pharmaceutical Co., Ltd Recent Developments/Updates
Table 126. Hunan Qianjin Xiangjiang Pharmaceutical Co., Ltd Competitive Strengths & Weaknesses
Table 127. Zhejiang Xianju Pharmaceutical Co., Ltd Basic Information, Manufacturing Base and Competitors
Table 128. Zhejiang Xianju Pharmaceutical Co., Ltd Major Business
Table 129. Zhejiang Xianju Pharmaceutical Co., Ltd Finasteride (Oral Route) Product and Services
Table 130. Zhejiang Xianju Pharmaceutical Co., Ltd Finasteride (Oral Route) Production (K Pcs), Price (US$/Pcs), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 131. Zhejiang Xianju Pharmaceutical Co., Ltd Recent Developments/Updates
Table 132. Zhejiang Xianju Pharmaceutical Co., Ltd Competitive Strengths & Weaknesses
Table 133. Shanghai Hyundai Pharmaceutical Co., Ltd Basic Information, Manufacturing Base and Competitors
Table 134. Shanghai Hyundai Pharmaceutical Co., Ltd Major Business
Table 135. Shanghai Hyundai Pharmaceutical Co., Ltd Finasteride (Oral Route) Product and Services
Table 136. Shanghai Hyundai Pharmaceutical Co., Ltd Finasteride (Oral Route) Production (K Pcs), Price (US$/Pcs), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 137. Shanghai Hyundai Pharmaceutical Co., Ltd Recent Developments/Updates
Table 138. Shanghai Hyundai Pharmaceutical Co., Ltd Competitive Strengths & Weaknesses
Table 139. Hunan Baicao Pharmaceutical Co., Ltd Basic Information, Manufacturing Base and Competitors
Table 140. Hunan Baicao Pharmaceutical Co., Ltd Major Business
Table 141. Hunan Baicao Pharmaceutical Co., Ltd Finasteride (Oral Route) Product and Services
Table 142. Hunan Baicao Pharmaceutical Co., Ltd Finasteride (Oral Route) Production (K Pcs), Price (US$/Pcs), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 143. Hunan Baicao Pharmaceutical Co., Ltd Recent Developments/Updates
Table 144. Hunan Baicao Pharmaceutical Co., Ltd Competitive Strengths & Weaknesses
Table 145. Guangdong Yishu Pharmaceutical Co., Ltd Basic Information, Manufacturing Base and Competitors
Table 146. Guangdong Yishu Pharmaceutical Co., Ltd Major Business
Table 147. Guangdong Yishu Pharmaceutical Co., Ltd Finasteride (Oral Route) Product and Services
Table 148. Guangdong Yishu Pharmaceutical Co., Ltd Finasteride (Oral Route) Production (K Pcs), Price (US$/Pcs), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 149. Guangdong Yishu Pharmaceutical Co., Ltd Recent Developments/Updates
Table 150. Guangdong Yishu Pharmaceutical Co., Ltd Competitive Strengths & Weaknesses
Table 151. CR SECCO Pharmaceutical Co., Ltd Basic Information, Manufacturing Base and Competitors
Table 152. CR SECCO Pharmaceutical Co., Ltd Major Business
Table 153. CR SECCO Pharmaceutical Co., Ltd Finasteride (Oral Route) Product and Services
Table 154. CR SECCO Pharmaceutical Co., Ltd Finasteride (Oral Route) Production (K Pcs), Price (US$/Pcs), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 155. CR SECCO Pharmaceutical Co., Ltd Recent Developments/Updates
Table 156. CR SECCO Pharmaceutical Co., Ltd Competitive Strengths & Weaknesses
Table 157. Shanghai Xinya Pharmaceutical Minhang Co., Ltd Basic Information, Manufacturing Base and Competitors
Table 158. Shanghai Xinya Pharmaceutical Minhang Co., Ltd Major Business
Table 159. Shanghai Xinya Pharmaceutical Minhang Co., Ltd Finasteride (Oral Route) Product and Services
Table 160. Shanghai Xinya Pharmaceutical Minhang Co., Ltd Finasteride (Oral Route) Production (K Pcs), Price (US$/Pcs), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 161. Shanghai Xinya Pharmaceutical Minhang Co., Ltd Recent Developments/Updates
Table 162. Shanghai Xinya Pharmaceutical Minhang Co., Ltd Competitive Strengths & Weaknesses
Table 163. Renhetang Pharmaceutical Company Limited Basic Information, Manufacturing Base and Competitors
Table 164. Renhetang Pharmaceutical Company Limited Major Business
Table 165. Renhetang Pharmaceutical Company Limited Finasteride (Oral Route) Product and Services
Table 166. Renhetang Pharmaceutical Company Limited Finasteride (Oral Route) Production (K Pcs), Price (US$/Pcs), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 167. Renhetang Pharmaceutical Company Limited Recent Developments/Updates
Table 168. Renhetang Pharmaceutical Company Limited Competitive Strengths & Weaknesses
Table 169. Runenberg Pharmaceuticals Ltd Basic Information, Manufacturing Base and Competitors
Table 170. Runenberg Pharmaceuticals Ltd Major Business
Table 171. Runenberg Pharmaceuticals Ltd Finasteride (Oral Route) Product and Services
Table 172. Runenberg Pharmaceuticals Ltd Finasteride (Oral Route) Production (K Pcs), Price (US$/Pcs), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 173. Runenberg Pharmaceuticals Ltd Recent Developments/Updates
Table 174. Runenberg Pharmaceuticals Ltd Competitive Strengths & Weaknesses
Table 175. Nanjing Shenghe Pharmaceutical Co., Ltd Basic Information, Manufacturing Base and Competitors
Table 176. Nanjing Shenghe Pharmaceutical Co., Ltd Major Business
Table 177. Nanjing Shenghe Pharmaceutical Co., Ltd Finasteride (Oral Route) Product and Services
Table 178. Nanjing Shenghe Pharmaceutical Co., Ltd Finasteride (Oral Route) Production (K Pcs), Price (US$/Pcs), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 179. Nanjing Shenghe Pharmaceutical Co., Ltd Recent Developments/Updates
Table 180. Nanjing Sea Whale Pharmaceutical Co., Ltd Basic Information, Manufacturing Base and Competitors
Table 181. Nanjing Sea Whale Pharmaceutical Co., Ltd Major Business
Table 182. Nanjing Sea Whale Pharmaceutical Co., Ltd Finasteride (Oral Route) Product and Services
Table 183. Nanjing Sea Whale Pharmaceutical Co., Ltd Finasteride (Oral Route) Production (K Pcs), Price (US$/Pcs), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 184. Global Key Players of Finasteride (Oral Route) Upstream (Raw Materials)
Table 185. Finasteride (Oral Route) Typical Customers
Table 186. Finasteride (Oral Route) Typical Distributors
LIST OF FIGURE
Figure 1. Finasteride (Oral Route) Picture
Figure 2. World Finasteride (Oral Route) Production Value: 2019 & 2023 & 2030, (USD Million)
Figure 3. World Finasteride (Oral Route) Production Value and Forecast (2019-2030) & (USD Million)
Figure 4. World Finasteride (Oral Route) Production (2019-2030) & (K Pcs)
Figure 5. World Finasteride (Oral Route) Average Price (2019-2030) & (US$/Pcs)
Figure 6. World Finasteride (Oral Route) Production Value Market Share by Region (2019-2030)
Figure 7. World Finasteride (Oral Route) Production Market Share by Region (2019-2030)
Figure 8. North America Finasteride (Oral Route) Production (2019-2030) & (K Pcs)
Figure 9. Europe Finasteride (Oral Route) Production (2019-2030) & (K Pcs)
Figure 10. China Finasteride (Oral Route) Production (2019-2030) & (K Pcs)
Figure 11. Japan Finasteride (Oral Route) Production (2019-2030) & (K Pcs)
Figure 12. Finasteride (Oral Route) Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Finasteride (Oral Route) Consumption (2019-2030) & (K Pcs)
Figure 15. World Finasteride (Oral Route) Consumption Market Share by Region (2019-2030)
Figure 16. United States Finasteride (Oral Route) Consumption (2019-2030) & (K Pcs)
Figure 17. China Finasteride (Oral Route) Consumption (2019-2030) & (K Pcs)
Figure 18. Europe Finasteride (Oral Route) Consumption (2019-2030) & (K Pcs)
Figure 19. Japan Finasteride (Oral Route) Consumption (2019-2030) & (K Pcs)
Figure 20. South Korea Finasteride (Oral Route) Consumption (2019-2030) & (K Pcs)
Figure 21. ASEAN Finasteride (Oral Route) Consumption (2019-2030) & (K Pcs)
Figure 22. India Finasteride (Oral Route) Consumption (2019-2030) & (K Pcs)
Figure 23. Producer Shipments of Finasteride (Oral Route) by Manufacturer Revenue ($MM) and Market Share (%): 2023
Figure 24. Global Four-firm Concentration Ratios (CR4) for Finasteride (Oral Route) Markets in 2023
Figure 25. Global Four-firm Concentration Ratios (CR8) for Finasteride (Oral Route) Markets in 2023
Figure 26. United States VS China: Finasteride (Oral Route) Production Value Market Share Comparison (2019 & 2023 & 2030)
Figure 27. United States VS China: Finasteride (Oral Route) Production Market Share Comparison (2019 & 2023 & 2030)
Figure 28. United States VS China: Finasteride (Oral Route) Consumption Market Share Comparison (2019 & 2023 & 2030)
Figure 29. United States Based Manufacturers Finasteride (Oral Route) Production Market Share 2023
Figure 30. China Based Manufacturers Finasteride (Oral Route) Production Market Share 2023
Figure 31. Rest of World Based Manufacturers Finasteride (Oral Route) Production Market Share 2023
Figure 32. World Finasteride (Oral Route) Production Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 33. World Finasteride (Oral Route) Production Value Market Share by Type in 2023
Figure 34. 1mg
Figure 35. 5mg
Figure 36. World Finasteride (Oral Route) Production Market Share by Type (2019-2030)
Figure 37. World Finasteride (Oral Route) Production Value Market Share by Type (2019-2030)
Figure 38. World Finasteride (Oral Route) Average Price by Type (2019-2030) & (US$/Pcs)
Figure 39. World Finasteride (Oral Route) Production Value by Application, (USD Million), 2019 & 2023 & 2030
Figure 40. World Finasteride (Oral Route) Production Value Market Share by Application in 2023
Figure 41. Urology
Figure 42. Dermatology
Figure 43. World Finasteride (Oral Route) Production Market Share by Application (2019-2030)
Figure 44. World Finasteride (Oral Route) Production Value Market Share by Application (2019-2030)
Figure 45. World Finasteride (Oral Route) Average Price by Application (2019-2030) & (US$/Pcs)
Figure 46. Finasteride (Oral Route) Industry Chain
Figure 47. Finasteride (Oral Route) Procurement Model
Figure 48. Finasteride (Oral Route) Sales Model
Figure 49. Finasteride (Oral Route) Sales Channels, Direct Sales, and Distribution
Figure 50. Methodology
Figure 51. Research Process and Data Source
